Market Overview

UPDATE: Abbott Posts Upbeat Q2 Profit

Share:
Related ABT
Here Are All The Big Biotech Mergers In 2016
St. Jude's Abbott Merger On Track For Q4
St. Jude Medical: A Great Short With 2.5x Risk/Reward (Seeking Alpha)

Abbott Laboratories (NYSE: ABT) reported a drop in its second-quarter profit.

Abbott's quarterly profit fell to $476 million, or $0.30 per share, versus $1.73 billion, or $1.08 per share, in the year-earlier quarter. Its adjusted earnings from continuing operations surged to $0.46 per share from $0.43 per share.

Its net sales jumped 2.5% to $5.45 billion from $5.31 billion. However, analysts were projecting earnings of $0.44 per share on sales of $5.52 billion.

Abbott shares closed at $35.70 yesterday.

Posted-In: profitEarnings News

 

Related Articles (ABT)

View Comments and Join the Discussion!